Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
1001
DELISTED
NxStage Medical Inc.
NXTM
| $10.2M | 0.02% |
380,232
+90,685
| +31% | +$2.51M |
|
1002
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $10.2M | 0.02% |
382,418
-236,514
| -38% | -$6.1M |
|
1003
Celestica
CLS
$37.1B
| $10.2M | 0.02% |
701,191
-125,605
| -15% | -$1.68M |
|
1004
Merit Medical Systems
MMSI
$5.39B
| $10.2M | 0.02% |
+352,498
| New | +$9.87M |
|
1005
Mueller Water Products
MWA
$3.93B
| $10.2M | 0.02% |
860,656
-992,111
| -54% | -$12.6M |
|
|
ACC
1006
DELISTED
American Campus Communities, Inc.
ACC
| $10.2M | 0.02% |
+213,328
| New | +$10.4M |
|
1007
Century Communities
CCS
$1.97B
| $10.2M | 0.02% |
399,626
+98,206
| +33% | +$2.27M |
|
1008
Autodesk
ADSK
$53.7B
| $10.1M | 0.02% |
117,288
-501,732
| -81% | -$42M |
|
1009
ICF International
ICFI
$1.59B
| $10.1M | 0.02% |
245,537
+68,907
| +39% | +$3.33M |
|
1010
PUT
Cognizant
CTSH
$28B
| $10.1M | 0.02% |
+170,000
| New | +$9.77M |
|
1011
Wendy's
WEN
$1.69B
| $10.1M | 0.02% |
742,834
+306,700
| +70% | +$4.18M |
|
1012
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.79B
| $10.1M | 0.02% |
+67,500
| New | +$10.5M |
|
1013
Kemper
KMPR
$1.63B
| $10.1M | 0.02% |
+253,334
| New | +$10.8M |
|
1014
Constellation Brands
STZ
$23.5B
| $10.1M | 0.02% |
62,296
-803,732
| -93% | -$125M |
|
|
WBMD
1015
DELISTED
WebMD Health Corp.
WBMD
| $10.1M | 0.02% |
191,464
+134,610
| +237% | +$6.88M |
|
1016
Astec Industries
ASTE
$1B
| $10.1M | 0.02% |
163,925
-44,419
| -21% | -$2.94M |
|
1017
Caterpillar
CAT
$373B
| $10.1M | 0.02% |
108,498
+2,912
| +3% | +$276K |
|
1018
Rigel Pharmaceuticals
RIGL
$843M
| $10.1M | 0.02% |
303,869
+147,661
| +95% | +$3.76M |
|
1019
Live Nation Entertainment
LYV
$43B
| $10M | 0.02% |
330,129
-450,019
| -58% | -$12.9M |
|
1020
Vail Resorts
MTN
$5.35B
| $10M | 0.02% |
52,241
+43,647
| +508% | +$7.73M |
|
1021
Ionis Pharmaceuticals
IONS
$10.3B
| $10M | 0.02% |
249,329
+244,954
| +5,599% | +$11M |
|
|
P
1022
DELISTED
Pandora Media Inc
P
| $10M | 0.02% |
848,697
-1,006,467
| -54% | -$12.6M |
|
1023
Darden Restaurants
DRI
$25.6B
| $10M | 0.02% |
+119,744
| New | +$8.97M |
|
1024
VEON
VEON
$4.21B
| $10M | 0.02% |
98,143
-47,178
| -32% | -$4.84M |
|
|
PTLA
1025
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $10M | 0.02% |
255,190
-877,089
| -77% | -$27.9M |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.